Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$XERS Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.18 down -1700.00% YoY • Reported revenue of $92.1M up 28.74% YoY • Xeris Biopharma Holdings tightened its full-year 2026 total revenue guidance to a range of $385 million to $390 million, reflecting the company's confidence in its portfolio and business trajectory.
2

Price since post

Full Details

Advertisement|Remove ads.